低剂量与高剂量皮质类固醇注射对手部软组织病理的有效性
Manish Pathuri1, Rishab H Bhatt1, Jeffrey G Stepan2
1Pritzker School of Medicine, Chicago, IL.
The Journal of hand surgery
|November 6, 2025
概括
高剂量氨注射 (40毫克) 与低剂量注射 (5-10毫克) 相比,在常见的手部疾病中表现出更高的疗效. 更高的剂量导致更好的症状缓解,减少了重复注射或手术的需要.
科学领域:
- 整形外科 整形外科 整形外科
- 手术手术手术手术手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨注射是手软组织病理的常见治疗方法.
- 在手部条件下,氨注射的最佳剂量仍在研究中.
- 常见的疾病包括触发指,手掌道综合征和德·奎尔温紧肌炎.
研究的目的:
- 为了评估高剂量 (40毫克) 与低剂量 (5-10毫克) 三素注射在手软组织病理方面的疗效.
- 为了比较疾病治愈率,二次注射的需要,以及不同剂量组之间的手术转换.
- 为了指导手部状况的最佳氨醇剂量策略.
主要方法:
- 从2020年到2023年,对466名患者 (649次注射) 的回顾性图表审查.
- 为触发指,手腕道综合征或德·奎尔韦恩紧关节炎接受氨的患者被分为高剂量和低剂量队列.
- 评估的结果包括症状缓解,症状持续时间,重复注射率和手术转换.
主要成果:
- 与低剂量注射相比,高剂量注射的重复注射率 (18%vs35%) 和手术转换率 (12%vs21%) 显著降低.
- 在高剂量组中,较少的患者经历了需要随访的持续症状 (26%与46%相比).
- 高剂量组在重复注射之间间隔较长 (12.0 vs 5.6 个月) 和预计手术时间较长 (11.1 vs 7.7 个月).
结论:
- 高剂量氨注射 (40毫克) 比低剂量注射 (5-10毫克) 更有效治疗触发指,手掌道综合征和德奎尔韦恩紧肌炎.
- 较高的氨醇剂量可以改善症状缓解的持续时间,减少重复注射的需要,并降低手术干预率.
- 手部外科医生应考虑使用更高剂量的三氨注射,以改善常见手部疾病的治疗结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
420
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
420
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
473
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
473


